5-hydroxydecanoate has been researched along with paclitaxel in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, JY; Chang, LY; Chen, LH; Chen, YF; Lee, MY; Shen, MR; Sun, YT | 1 |
1 other study(ies) available for 5-hydroxydecanoate and paclitaxel
Article | Year |
---|---|
Integrating Image-Based High-Content Screening with Mouse Models Identifies 5-Hydroxydecanoate as a Neuroprotective Drug for Paclitaxel-Induced Neuropathy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Calcium Signaling; Cell Line, Tumor; Cell Survival; Decanoic Acids; Female; Ganglia, Spinal; Humans; Hydroxy Acids; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Neurons; Neuroprotective Agents; Paclitaxel; Peripheral Nervous System Diseases; Primary Cell Culture; Sciatic Nerve; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |